Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1993 Feb 19;15(1):10-6.
doi: 10.1007/BF02116164.

Development and registration of chiral drugs

D T Witte  1 , K Ensing, J P Franke, R A De Zeeuw
Affiliations
Review

Development and registration of chiral drugs

D T Witte et al. Pharm World Sci. .

Abstract

In this review we describe the impact of chirality on drug development and registration in the United States, Japan and the European Community. Enantiomers may have differences in their pharmacological profiles, and, therefore, chiral drugs ask for special analytical and pharmacological attention during their development. However, the registration authorities have no clear policy towards the registration of chiral drugs. The absence of a clear policy regarding chirality causes a great deal of confusion and frustration at various levels and is not in the interest of industries developing newer and more beneficial drugs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1981 Mar;29(3):344-50 - PubMed
    1. J Pharm Sci. 1976 Feb;65(2):238-42 - PubMed
    1. Chirality. 1991;3(3):165-9 - PubMed
    1. Clin Pharmacol Ther. 1989 Nov;46(5):584-90 - PubMed
    1. Biochim Biophys Acta. 1991 Jul 12;1078(3):411-7 - PubMed

Substances

LinkOut - more resources